Hans-Georg Sprenger

Dr. Hans-Georg Sprenger is a Max Planck Research Group Leader at the Max Planck Institute for Biology of Ageing and a Principal Investigator at CECAD (Cluster of Excellence in Aging Research) at the University of Cologne. His work focuses on molecular mechanisms linking mitochondrial function, metabolic homeostasis, and aging-related diseases.

• Education: PhD in Biological Sciences (University of Cologne, 2014–2018)
• Postdoctoral Training: Harvard Medical School, Dana-Farber Cancer Institute, MIT, Whitehead Institute

Research Interests:
Dr. Sprenger investigates how mitochondrial metabolism adapts to environmental stressors like exercise, diet, and aging. His group explores small molecules that regulate mitochondrial function and their therapeutic potential for age-related metabolic disorders.

Scientific Awards:

• Travel Award, Dana-Farber Cancer Institute (2024)
• Postdoctoral Fellowship, Hope Funds for Cancer Research (2021)
• DFG Postdoctoral Fellowship (2020)
• FEBS Journal Best Poster Award (2019)
• PhD and Fast-Track Fellowships (2013–2014)

Advising: Mentoring doctoral students including Fabian Bäzner, Mahshid Mohsenzadeh Hedesh, Saba Nateghi, and Margareta Sacer through the IMPRS program.